Al Windham is a seasoned litigator who draws upon his unique blend of legal and medical knowledge to advise and successfully defend his clients. For nearly 20 years, Al has counseled manufacturers in the retail and consumer goods industry, helping them navigate complex, products liability and mass torts litigation. Al has experience in all phases of discovery and trial. In particular, Al has significant experience in formulating defensive medical strategy in multi-jurisdictional tobacco and pharmaceutical litigation. Al routinely consults with prominent medical experts from around the country, deciphering medical evidence and assessing medical causation.
Al possesses a deep understanding of various medical issues, including lung cancer, head and neck cancer, COPD, emphysema, cardiac disease and stroke, as well as associated risk factors. Over his career, Al has consistently provided a thorough analysis of medical causation, developed a strong rapport with medical experts, and earned the trust of his colleagues and clients.
Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients.
- Defends R.J. Reynolds Tobacco Company in personal injury and wrongful death cases in multiple state and federal jurisdictions, working closely with national counsel and medical experts in a variety of disciplines, including pathology, radiology, oncology, pulmonology, otolaryngology, cardiology, neurology and toxicology.
- Defended a multinational pharmaceutical manufacturer in fenfluramine/dexfenfluramine diet drug litigation, assessing alleged adverse events, including valvular regurgitation and cerebrovascular vascular accidents.
- Defended manufacturer of synthetic stucco/EIFS (exterior insulation finish systems), examining alleged “sick building syndrome” and complaints of respiratory and neurological symptoms from exposure to stachybotrys chartarum and other types of toxic mold.
- Defended manufacturer of polyester fibers, yarns and staples in antitrust litigation.